Employees Retirement System of Texas’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-81,000
Closed -$983K 748
2022
Q1
$983K Buy
81,000
+37,000
+84% +$779K 0.01% 652
2021
Q4
$1.5M Hold
44,000
0.02% 586
2021
Q3
$2.12M Hold
44,000
0.02% 556
2021
Q2
$1.99M Hold
44,000
0.02% 570
2021
Q1
$2.12M Buy
+44,000
New +$2.29M 0.03% 562
2019
Q3
Sell
-25,000
Closed -$549K 1040
2019
Q2
$549K Buy
+25,000
New +$549K 0.01% 949

Other funds holding NEO

Employees Retirement System of Texas's NEO Position: Q2 2022 in Review

Employees Retirement System of Texas sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 81,000 shares — an estimated $983K sold.

Employees Retirement System of Texas first reported a position in NEO in Q2 2019 and held it in 6 quarters. The position peaked at $2.12M in Q3 2021. 240 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

  • Employees Retirement System of Texas reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
  • Employees Retirement System of Texas sold 81,000 NeoGenomics shares in Q2 2022, an estimated $983K.
  • Employees Retirement System of Texas first reported a position in NeoGenomics in Q2 2019 and held it in 6 quarters.
  • Employees Retirement System of Texas's NeoGenomics position peaked at $2.12M in Q3 2021.
  • 240 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Employees Retirement System of Texas's 13F filing for Q2 2022, filed 8 Aug 2022.